Does GUSELKUMAB Cause Interstitial lung disease? 28 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Interstitial lung disease have been filed in association with GUSELKUMAB (TREMFYA). This represents 0.1% of all adverse event reports for GUSELKUMAB.
28
Reports of Interstitial lung disease with GUSELKUMAB
0.1%
of all GUSELKUMAB reports
3
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From GUSELKUMAB?
Of the 28 reports, 3 (10.7%) resulted in death, 10 (35.7%) required hospitalization, and 4 (14.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GUSELKUMAB. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does GUSELKUMAB Cause?
Product dose omission issue (9,267)
Accidental exposure to product (2,941)
Drug ineffective (1,971)
Needle issue (1,933)
Psoriasis (1,817)
Device issue (1,613)
Device malfunction (1,410)
Off label use (1,186)
Product storage error (1,017)
Inappropriate schedule of product administration (830)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which GUSELKUMAB Alternatives Have Lower Interstitial lung disease Risk?
GUSELKUMAB vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUSELKUMAB vs HALDOL
GUSELKUMAB vs HALOBETASOL
GUSELKUMAB vs HALOPERIDOL
GUSELKUMAB vs HALOPERIDOL DECANOATE